genedrive plc (GDR.L)
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, which incorporates various user-led improvements to its small, patented gene amplification platform for ease of use in time critical situations, and to simplify workflow, as well as for professional use in emergency healthcare settings. Its Genedrive platform offers Genedrive HCV ID Kit, a qualitative molecular solution for Hepatitis C Virus testing; Genedrive BioPlex for targeting various pathogens in the defense applications; Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and Genedrive COV19-ID Kit, an innovative rapid point-of care molecular test for COVID-19. It serves medical, biotechnology, and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.
Company Info
ISIN | GB00B1VKB244 |
---|---|
Sector | Healthcare |
Industry | Diagnostics & Research |
Highlights
Market Cap | £7.69M |
---|---|
EPS | -£0.05 |
PE Ratio | 276.37 |
Revenue (TTM) | £272.00K |
Gross Profit (TTM) | -£3.82M |
EBITDA (TTM) | -£4.85M |
Year Range | £2.56 - £25.90 |
Target Price | £85.00 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: GDR.L vs. AZN.L
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in genedrive plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
genedrive plc had a return of -45.85% year-to-date (YTD) and -76.53% in the last 12 months. Over the past 10 years, genedrive plc had an annualized return of -34.92%, while the S&P 500 had an annualized return of 10.41%, indicating that genedrive plc did not perform as well as the benchmark.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -45.85% | 6.17% |
1 month | 17.33% | -2.72% |
6 months | -46.67% | 17.29% |
1 year | -76.53% | 23.80% |
5 years (annualized) | -26.69% | 11.47% |
10 years (annualized) | -34.92% | 10.41% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -21.54% | -21.57% | -32.50% | 51.85% | ||||||||
2023 | -15.85% | -28.99% | 32.65% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of GDR.L is 12, indicating that it is in the bottom 12% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
genedrive plc(GDR.L)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for genedrive plc (GDR.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the genedrive plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the genedrive plc was 99.46%, occurring on Mar 26, 2024. The portfolio has not yet recovered.
The current genedrive plc drawdown is 99.24%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-99.46% | Aug 5, 2013 | 2687 | Mar 26, 2024 | — | — | — |
-31.33% | Jan 26, 2010 | 83 | Aug 25, 2010 | 292 | Sep 13, 2012 | 375 |
-28.57% | Apr 25, 2008 | 54 | Oct 29, 2008 | 1 | Nov 3, 2008 | 55 |
-20.56% | May 29, 2007 | 53 | Feb 15, 2008 | 18 | Apr 18, 2008 | 71 |
-17.81% | Jun 3, 2009 | 31 | Aug 14, 2009 | 12 | Oct 6, 2009 | 43 |
Volatility
Volatility Chart
The current genedrive plc volatility is 52.07%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |